WCE 2017: Minimally Invasive Inguinal Lymphadenectomy: A Pilot Feasibility Series

Vancouver, Canada (UroToday.com) Dr. Nathan Jung, a resident at the University of Tennessee Chatanooga, presented his team’s experience with the significant morbidity and complication rates associated with inguinal lymphadenectomies (ILN). These risks place a heavy burden on both the patient and the health care system. 

Dr. Jung and his team proposed that decreased incision size and elimination of a coverage flap may limit complications and decrease morbidity. The purpose of this study was for Dr. Jung and his team to present their initial experiences with minimally invasive laparoscopic (LILN) and robot-assisted (RAILN).

For this evaluation, Dr. Jung and his team retrospectively reviewed all laparoscopic (LILN) and robot-assisted (RAILN) at their institution from September 2013 until July 2017. To avoid selection bias, all patients appropriate for an open ILN were offered a minimally invasive LILN or RAILN. Data was collected on a total of 10 groins from 7 patients. In this greater saphenous-sparing approach, a Spacemaker balloon (Medtronic, Minneapolis, MN) was deployed superficial to the fascia lata. The lymph nodes were then dissected free using ports placed in the thigh.

Dr. Jung and his team’s initial experience with LILN and RAILN were associated with minimal morbidity and a decreased hospital length of stay. Dr. Jung completed his presentation by emphasizing that control-matched prospective cohort studies are needed to further evaluate these conclusions. 

Presented by: Nathan Jung, MD 

Authors: Nathan Jung, Hugh Smith, Amanda Carter, Chris Keel, D.O. Daniel Herz, and Amar Singh
Affiliation: The University of Tennessee College of Medicine Chatanooga/Erlenger Health, Chattanooga, Tennessee

Written by: Taylor Capretz, Department of Urology, University of California- Irvine at 35th World Congress of Endourology– September 12-16, 2017, Vancouver, Canada.